Novartis’ Lp(a) drug shows zero benefit, casting shadow over Amgen and Lilly programs
Fierce Biotech How Cardiologists’ High Hopes for Two Drugs Were Dashed The New York Times A promising new medicine against heart disease fails unexpectedly NPR Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors CNN The ‘slam…
The report was published on 07 de novembro de 2026 às 11:50 by Fierce Biotech and is part of the Business coverage.
Quick answers
Who reported this story?
It was first reported by Fierce Biotech on 07 de novembro de 2026 às 11:50.
What is the category?
It is filed under Business on Rio Warzone News.
